So, there's this company called Apple that makes smartwatches. These watches can do many things, including checking how much oxygen is in your blood. But another company, Masimo, said that Apple was using their idea to check blood oxygen without permission. A group of people who decide if something is fair decided that Apple was wrong and stopped them from selling watches with this feature in the U.S. for a while. Now, Apple has made new watches that don't have the blood oxygen checking thing, so they can still sell them in the U.S. while they try to fix the problem. Read from source...

1. The title is misleading and sensationalized. It implies that Apple Watch versions without blood oxygen feature are going on sale in the US because of a ban, when in reality, it is due to a patent dispute with Masimo Corporation, which led to a temporary halt on sales of Apple's watches in December 2023.
2. The article does not provide any background information or context about the intellectual property dispute between Apple and Masimo. It would be helpful for readers to understand why this issue arose and what it means for both companies involved.
3. The article uses terms like "looming ban" and "sidestep" which convey a negative tone and make it seem like Apple is acting unethically or dishonestly, rather than trying to comply with the ruling while ensuring customers have access to their products.
4. The article does not mention any potential benefits of removing the blood oxygen feature, such as reducing production costs, simplifying the design, or focusing on other features that may be more important to customers. It also fails to acknowledge that some users might still find value in the watch without this specific function.
5. The article ends with a quote from an Apple spokesperson, but does not provide any analysis or commentary on it. This leaves readers with incomplete information and no clear understanding of how Apple is addressing the issue.

Neutral
Explanation: The article is reporting on a factual situation regarding Apple's decision to release a variant of its watches without a blood oxygen feature due to an intellectual property dispute. It does not express any strong opinions or emotions about the situation, nor does it predict how this will affect Apple's future performance. Therefore, the sentiment is neutral.